Cockroach's brains is Healthy for Humans

Cockroaches are usually seen as a dangerous animal health, can be found in damp places and dirty hotel. But scientists believe that they could hold the secret to treat the most formidable insects. According to the Daily Mail, testing has found a network of brain and nervous system of insects can kill more than 90 percent of MRSA infections and E-coli without harming human cells.

Simon Lee, a postgraduate researcher from the University of Nottingham said that the cockroach has strong antibiotic properties after discovering nine different molecules in cockroach tissues that are toxic to bacteria. He said: "We hope that the molecule may eventually be developed into drugs for E-coli and MRSA infections are increasingly vulnerable to current drugs. "These new antibiotics could potentially provide an alternative to currently available medications, current medications may be effective but have serious side effects and unwanted." He added: "Insects often live in an environment that is unhealthy and unhygienic where they face various kinds of bacteria. It is therefore logical ways memngembangkan insect defenses to protect themselves against micro-organisms. " Mr Lee's research focuses on the study of specific properties of antibacterial molecules that are currently being tested in these super bugs. According to the Society for General Microbiology, industrial pharmacy is producing fewer and fewer new antibiotics due to lack of financial incentives, so that high demand for alternative sources of new drugs.

Tomorrow, Mr Lee will present his findings before the public meeting of friends of scientists in the fall at the University of Nottingham. Dr Naveed Khan oversees the work Lee. He said: "superbugs like MRSA Insects have developed resistance to standard therapies and treatments that we do. "They have demonstrated the ability to infections that can not be cured, and has become a major threat in our fight against bacterial diseases. So, there is a constant need to find additional sources of new antimicrobial to deal with this threat. "